Browsing "1. Journal Papers" by Author : 2426

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 16 of 16

This table browses all dspace content
Issue DateTitleJournal Title
2012A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancerEUROPEAN JOURNAL OF CANCER
2022Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin CANCERS
2019Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea CANCER RESEARCH AND TREATMENT
2024Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II StudyCLINICAL CANCER RESEARCH
2020Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CAONCOLOGY
2016Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After GastrectomyANNALS OF SURGERY
2024Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial NATURE COMMUNICATIONS
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus ONCOTARGET
2021PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma BMC CANCER
2021Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial ESMO OPEN
2022Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaCLINICAL CANCER RESEARCH
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2021Prognostic implications of PD-L1 expression in patients with angiosarcoma FUTURE SCIENCE OA
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial CANCER RESEARCH AND TREATMENT
2015The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancerLUNG CANCER
1

Browse

Links